Is there a generic for Inamrinone lactate?

Yes. The FDA Orange Book lists 3 approved generic (ANDA) applications for Inamrinone lactate, referencing the brand INOCOR. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Inamrinone lactate?

INOCOR (NDA 018700, SANOFI AVENTIS US) is the reference-listed drug — the approved product a generic applicant must show its version is the same as.

What dosage forms of Inamrinone lactate are approved?

Inamrinone lactate is approved in the following dosage form: injectable.

FDA Orange Book · active-ingredient family

Inamrinone lactate

Inamrinone lactate is approved as 1 brand and 3 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:INOCOR · NDA 018700

Brand (NDA)

Generics (ANDA)

Listed patents

Exclusivity periods

Brand (NDA) products · injectable

Product	Applicant	Application	TE	Approved
INOCOR	SANOFI AVENTIS US	NDA 018700	—	Jul 31, 1984

Generic (ANDA) products (3)

Product	Applicant	Application	TE	Approved
AMRINONE LACTATE	BAXTER HLTHCARE CORP	ANDA 075542	—	May 10, 2000
AMRINONE LACTATE	HIKMA	ANDA 075513	—	May 09, 2000
AMRINONE LACTATE	HOSPIRA	ANDA 074616	—	Aug 03, 1998

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Inamrinone lactate — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo